Form 8-K - Current report:
SEC Accession No. 0001104659-22-125539
Filing Date
2022-12-08
Accepted
2022-12-08 17:29:10
Documents
13
Period of Report
2022-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232162d1_8k.htm   iXBRL 8-K 30822
2 EXHIBIT 10.1 tm2232162d1_ex10-1.htm EX-10.1 59600
  Complete submission text file 0001104659-22-125539.txt   281686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnk-20221208.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20221208_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20221208_pre.xml EX-101.PRE 22602
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2232162d1_8k_htm.xml XML 3807
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1230
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 221453266
SIC: 2834 Pharmaceutical Preparations